Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis

NCT00004196 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3000

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: recombinant interferon alfa
PROCEDURE: lymphangiography
DRUG: Observation

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]